Calliditas får fullt godkännande i USA för njurläkemedel

Svenska Calliditas har fått ett fullt godkännande i USA för Tarpeyo, en behandling för den allvarliga njursjukdomen primär immunoglobulin A-nefropati (IgAN).

The Swedish government is to increase its investment in cancer care

The Swedish government wants to invest more in cancer and paediatric cancer care and proposes to allocate SEK 500 million per year for this purpose in the coming years.

Lockdown-studie kritiseras även i USA

I USA har den uppmärksammade metastudie som uppger att knappt några liv har räddats med hjälp av lockdowns blivit kraftigt ifrågasatt av forskare.

Faster development of reliable sample handling

Festo USA has collaborated with PerkinElmer to develop a compact sample handling solution for a global leader in manufacturing medical devices. Thanks to the cu...

MedVasc and Scientific Solutions join forces to streamline FDA 510(k) regulatory process

MedVasc, an exciting MedTech startup company, and Scientific Solutions, a renowned consulting firm within Life Science, are pleased to announce a strategic part...

Första bekräftade dödsfallet i omikron i Storbritannien

Minst en person har dött i omikronvarianten i Storbritannien. Det uppger premiärminister Boris Johnson.

Konglomerat lägger bud på Calliditas

Japanska konglomeratet Ashai Kasei har lagt ett bud på det svenska läkemedelsbolaget Calliditas Therapeutics. Styrelsen rekommenderar att bolagets ägare godkänner erbjudandet.

Why the world renown researcher Marc Tessier-Lavigne resigns as Stanford´s president

In mid-summer, neuroscientist Marc Tessier-Lavigne announced his resignation as President of Stanford following allegations of manipulated study data. According...

Uppköpsbudet fullföljs – Calliditas tas över av japanskt konglomerat

Japanska Asahi fullföljer budet på Calliditas Therapeutics efter att ha nått över 90 procent av aktieinnehavet. Calliditas styrelse har nu beslutat att ansöka o...

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...

Investments worth 40 billion in the Öresund region – “A huge investment wave”

A new report reveals that medical companies in the Oresund region are investing like never before.

Pilots want to live too

Learn from Speakers from Leading MedTech Companies

Watch the recordings from ZEISS Quality Innovation Days whenever it suits you.

How Volume EM Advances Life Science Research

Free webinar series.

Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

Fast Optical Sectioning of Developing Organisms and Tissue Microstructures

ZEISS Lattice SIM 3 exploits the full potential of the SIM Apotome technology.

Happy International Women's Day!

This March, we're dedicating Fridays to spotlight women in STEM. The first article is about Helena, a Sales Engineer in Sweden. Read why she likes to work with ...

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of De...

Studie: Hjärtbox gav färre komplikationer än kylväska vid transplantation

En svenskutvecklad metod för att förvara donerade hjärtan inför transplantation minskar risken för patienten att drabbas av tidig hjärtsvikt, enligt en ny studi...

Uppgifter: Amerikanskt företag vill förvärva Sobi

Det amerikanska riskkapitalbolaget Advent International överväger att lägga ett bud på svenska Sobi, enligt uppgifter.

Behöver du vätskekylning under noll grader?

SMC erbjuder cirkulationskylare för en rad olika appikationer och temperaturer, minusgrader inkluderat. Kontakta oss så hittar vi rätt lösning för dig!

Festo liquid dispensing: going fast and slow

Dispensing liquid with Festo equipment developed for automation can really be adapted to your needs

The First Multi-Technology System from ZEISS

Microscope and measuring machine in one.

Tirzepatide approved for obesity by the FDA – to be branded as Zepbound

Diabetes drug tirzepatide has now also been approved in the US for treating obesity.